Search Results - "FILLIT, Howard"
-
1
Aducanumab and the FDA — where are we now?
Published in Nature reviews. Neurology (01-03-2021)“…The amyloid antibody aducanumab is currently undergoing review by the FDA. The treatment would be the first disease-modifying drug to be approved for Alzheimer…”
Get full text
Journal Article -
2
Translating the biology of aging into novel therapeutics for Alzheimer disease
Published in Neurology (08-01-2019)“…Aging is the leading risk factor for most chronic illnesses of old age, including Alzheimer disease (AD), a progressive neurodegenerative disease with…”
Get full text
Journal Article -
3
Dementia Diagnosis Disparities by Race and Ethnicity
Published in Medical care (01-08-2021)“…Background: Dementia is often underdiagnosed and this problem is more common among some ethnoracial groups. Objective: The objective of this study was to…”
Get full text
Journal Article -
4
Medicare Expenditures of Individuals with Alzheimer's Disease and Related Dementias or Mild Cognitive Impairment Before and After Diagnosis
Published in Journal of the American Geriatrics Society (JAGS) (01-08-2016)“…Objectives To characterize Medicare expenditure and usage trends in individuals with a coded diagnosis of Alzheimer's disease and related dementia (ADRD) or…”
Get full text
Journal Article -
5
A Brain Capital Grand Strategy: toward economic reimagination
Published in Molecular psychiatry (01-01-2021)“…‘I have not found among my possessions anything which I hold more dear than, or value so much as, my knowledge of the actions of great people, acquired by long…”
Get full text
Journal Article -
6
Developing novel blood-based biomarkers for Alzheimer's disease
Published in Alzheimer's & dementia (01-01-2014)“…Abstract Alzheimer's disease is the public health crisis of the 21st century. There is a clear need for a widely available, inexpensive and reliable method to…”
Get full text
Journal Article -
7
The clinical promise of biomarkers of synapse damage or loss in Alzheimer's disease
Published in Alzheimer's research & therapy (02-03-2020)“…Synapse damage and loss are fundamental to the pathophysiology of Alzheimer's disease (AD) and lead to reduced cognitive function. The goal of this review is…”
Get full text
Journal Article -
8
A call for transparent reporting to optimize the predictive value of preclinical research
Published in Nature (London) (11-10-2012)“…Deficiencies in methods reporting in animal experimentation lead to difficulties in reproducing experiments; the authors propose a set of reporting standards…”
Get full text
Journal Article -
9
Potentially avoidable hospitalizations among Medicare beneficiaries with Alzheimer’s disease and related disorders
Published in Alzheimer's & dementia (01-01-2013)“…Abstract Background Individuals with Alzheimer's disease and related disorders (ADRD) have more frequent hospitalizations than individuals without ADRD, and…”
Get full text
Journal Article -
10
Racial and Ethnic Differences in Knowledge About One's Dementia Status
Published in Journal of the American Geriatrics Society (JAGS) (01-08-2020)“…OBJECTIVES To examine racial and ethnic differences in knowledge about oneʼs dementia status. DESIGN Prospective cohort study. SETTING The 2000 to 2014 Health…”
Get full text
Journal Article -
11
The Frailty Identity Crisis
Published in Journal of the American Geriatrics Society (JAGS) (01-02-2009)“…Frailty is a common and central problem of old age. Recent research has defined frailty as an accumulation of deficits or as a distinct clinical syndrome…”
Get full text
Journal Article -
12
Racial and ethnic differences in disease course Medicare expenditures for beneficiaries with dementia
Published in Journal of the American Geriatrics Society (JAGS) (01-04-2024)“…Background Research on racial and ethnic disparities in costs of care during the course of dementia is sparse. We analyzed Medicare expenditures for…”
Get full text
Journal Article -
13
Treatment patterns and burden of behavioral disturbances in patients with dementia in the United States: a claims database analysis
Published in BMC neurology (28-02-2019)“…Although patients with dementia frequently experience neuropsychological symptoms (NPS) such as agitation, which profoundly impacts patients, caregivers, and…”
Get full text
Journal Article -
14
Hospitalizations for ambulatory care sensitive conditions and unplanned readmissions among Medicare beneficiaries with Alzheimer's disease
Published in Alzheimer's & dementia (01-10-2017)“…Medicare beneficiaries with Alzheimer's disease and related dementias (ADRDs) may have more potentially avoidable hospitalizations and readmissions than people…”
Get full text
Journal Article -
15
Value-Generating Exploratory Trials in Neurodegenerative Dementias
Published in Neurology (18-05-2021)“…Drug development for Alzheimer disease and other neurodegenerative dementias, including frontotemporal dementia, has experienced a long history of phase 2 and…”
Get full text
Journal Article -
16
Alzheimer's disease medication use and adherence patterns by race and ethnicity
Published in Alzheimer's & dementia (01-04-2023)“…Background We examined racial and ethnic differences in medication use for a representative US population of patients with Alzheimer's disease and related…”
Get full text
Journal Article -
17
Life-Sustaining Treatments Among Medicare Beneficiaries with and without Dementia at the End of Life
Published in Journal of Alzheimer's disease (01-01-2023)“…Older adults with dementia including Alzheimer's disease may have difficulty communicating their treatment preferences and thus may receive intensive…”
Get more information
Journal Article -
18
Improving dementia care: The role of screening and detection of cognitive impairment
Published in Alzheimer's & dementia (01-03-2013)“…Abstract The value of screening for cognitive impairment, including dementia and Alzheimer's disease, has been debated for decades. Recent research on causes…”
Get full text
Journal Article -
19
Artificial Intelligence–Powered Digital Health Platform and Wearable Devices Improve Outcomes for Older Adults in Assisted Living Communities: Pilot Intervention Study
Published in JMIR aging (10-09-2020)“…Background Wearables and artificial intelligence (AI)–powered digital health platforms that utilize machine learning algorithms can autonomously measure a…”
Get full text
Journal Article -
20
End‐of‐life burdensome interventions among Medicare fee‐for‐service beneficiaries with no dementia, non‐advanced dementia, and advanced dementia
Published in Alzheimer's & dementia (01-12-2022)“…Background Older adults with dementia have difficulties communicating their treatment preferences and experience end‐of‐life burdensome interventions with…”
Get full text
Journal Article